Publications

• Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2.
  Ann Surg
  04/11/2025 Authors: Renfro LA; Vallance KL; Tfirn IC; Evageliou N; Benedetti DJ; Shamberger RC; Ehrlich PF; Cost NG; Aldrink JH; Schechter A
• Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting.
  Pediatr Blood Cancer Volume: 72 Page(s): e31347
  01/01/2025 Authors: Schneller N; Daw N; Throckmorton W; Mullen E; DeSmith K; Mascarenhas L; O'Connell C; Fernandez CV; Sutton KS; Venkatramani R
• Consult Questions: Communication is Key.
  Acad Pediatr Volume: 24 Page(s): 893 - 894
  08/01/2024 Authors: Thomas MW; Sutton KS; Wallace S; Wilhelm CM
• Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy.
  J Transl Med Volume: 22 Page(s): 256
  03/09/2024 Authors: Bai J; Eldridge R; Houser M; Martin M; Powell C; Sutton KS; Noh HI; Wu Y; Olson T; Konstantinidis KT
• The tumor microenvironment and immune targeting therapy in pediatric renal tumors.
  Pediatr Blood Cancer Volume: 70 Suppl 2 Page(s): e30110
  05/01/2023 Authors: Hont AB; Dumont B; Sutton KS; Anderson J; Kentsis A; Drost J; Hong AL; Verschuur A
• Gut microbiome associated with the psychoneurological symptom cluster among children with solid tumors receiving chemotherapy
  Volume: 83
  04/01/2023 Authors: Bai J; Martin M; Sutton KS; Powell C; Olson T; Noh HI; Swartz MC; Bruner DW
• How to Maintain a Healthy Gut Microbiome in Children with Cancer? Gut Microbiome Association with Diet in Children with Solid Tumors Postchemotherapy.
  OMICS Volume: 26 Page(s): 236 - 245
  04/01/2022 Authors: Zhou S; Martin M; Powell C; Sutton KS; George B; Olson T; Konstantinidis KT; Bruner DW; Bai J
• Head and Neck Langerhans Cell Histiocytosis in Children.
  J Oral Maxillofac Surg Volume: 80 Page(s): 545 - 552
  03/01/2022 Authors: Xu J; Gilbert JR; Sutton KS; Goudy SL; Abramowicz S
• Lch Involving the head and Neck: A single Pediatric institution Experience
  Volume: 69 Page(s): S8 - S8
  01/01/2022 Authors: Gilbert J; Xu JY; Goudy SL; Abramowicz S; Sutton KS
• Progress Update in Pediatric Renal Tumors.
  Curr Oncol Rep Volume: 23 Page(s): 33
  02/16/2021 Authors: Jain J; Sutton KS; Hong AL
• Dealing with a critical national shortage-Approaches to triaging immune globulin supply in pediatric hematology and oncology.
  Pediatr Blood Cancer Volume: 67 Page(s): e28260
  07/01/2020 Authors: Edington HJ; Sutton KS; Bennett C; Chandrakasan S; Sterner-Allison J; Castellino SM
• Ex vivo expanded patient-derived T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.
  Oncoimmunology Volume: 8 Page(s): 1593804
  01/01/2019 Authors: Zoine JT; Knight KA; Fleischer LC; Sutton KS; Goldsmith KC; Doering CB; Spencer HT
• The properties of ex vivo expanded gamma delta T cells provide for the rational use of combination therapies
  Volume: 78
  10/01/2018 Authors: Zoine JT; Sutton KS; Knight KA; Goldsmith KC; Doering CB; Spencer HT
• Engineering Ex Vivo Serum-Free Expanded (Y)delta T Cells for the Treatment of Neuroblastoma
  Volume: 25 Page(s): 278 - 279
  05/01/2017 Authors: Zoine JT; Sutton KS; Goldsmith KC; Dasgupta A; McCarty D; Doering CB; Spencer HT
• Bioengineering and serum free expansion of blood-derived T cells.
  Cytotherapy Volume: 18 Page(s): 881 - 892
  07/01/2016 Authors: Sutton KS; Dasgupta A; McCarty D; Doering CB; Spencer HT
• Expansion and Bioengineering of Peripheral Blood-Derived Anti-Cancer Gd T Cells in Serum Free Media
  Volume: 126
  12/03/2015 Authors: Sutton KS; Dasgupta A; McCarty D; Doering CB; Spencer HT
• Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
  Volume: 23 Page(s): S115 - S115
  05/01/2015 Authors: Spencer HT; Pereboeva L; Gillespie GY; Dasgupta A; Sutton KS; Lamb LS
• Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
  Volume: 21 Page(s): S240 - S240
  02/01/2015 Authors: Spencer HT; Dasgupta A; Gillespie GY; Pereboeva L; Sutton KS; Lamb L
• Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia.
  Pediatr Blood Cancer Volume: 60 Page(s): 455 - 460
  03/01/2013 Authors: Sutton KS; Shereck EB; Nemecek ER; Kurre P